NCT04423458

Brief Summary

This study evaluates the role of advanced US technology in assessing renal transplants as screening tools such as 3D Ultrasound, Ultrasound SWE, and MFI besides current ultrasound conventional metheds.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 4, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

9 months

First QC Date

June 5, 2020

Last Update Submit

February 6, 2023

Conditions

Keywords

3D UltrasoundUS elastographyUS MFIUltrasoundMRICT

Outcome Measures

Primary Outcomes (3)

  • Peak systolic velocity (cm/s).

    Pean of the blood flow velocities in the artery/ vein peak systolic velocity ≥200 cm/s velocity difference between pre- and post-stenotic segments of 2:1

    12 weeks

  • Peak systolic velocity ratio (PSVR).

    High velocity flow at the stenosis site divided by a reference velocity (normal before stenosis)

    12 weeks

  • Resistive Index (RI).

    An RI less than 0.7 to 0.8 is considered normal, more than that it is indicator of transplant dysfunction.

    12 weeks

Secondary Outcomes (2)

  • Volumetric stenosis.

    12 weeks

  • 3D GSM.

    12 weeks

Study Arms (1)

Transplanted kidney

No intervention is required. Routine Doppler assessment + 3D scan + Shear wave elastography + MicrFlow Imaging will be immediately recorded afterwards

Device: 3D imaging

Interventions

The study will focus on the accuracy of ultrasound technology in assessing renal transplants. The entire assessment should not take more than 25 minutes.

Transplanted kidney

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients having /had kindey transplant

You may qualify if:

  • Patients ≥ 18 years.
  • Tx patients.
  • Gender.

You may not qualify if:

  • Prisoners.
  • Patients \< 18 years.
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College London

London, W12 0HS, United Kingdom

Location

MeSH Terms

Conditions

Renal InsufficiencyRenal Insufficiency, ChronicRenal Artery ObstructionFibrosis

Interventions

Imaging, Three-Dimensional

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mohammed Aslam, PhD

    Academic Supervisor

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

January 4, 2022

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations